InnovAge Holding Corp (INNV) FinancialsINNVInnovAge Holding Corp

InnovAge Holding Corp (INNV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pace, accounting for 99.9% of total sales, equivalent to $235.85M. Another important revenue stream is All others. Understanding this composition is critical for investors evaluating how INNV navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, InnovAge Holding Corp maintains a gross margin of 22.27%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.48%, while the net margin is -11.88%. These profitability ratios, combined with a Return on Equity (ROE) of -4.97%, provide a clear picture of how effectively INNV converts its operational activities into shareholder value.

In the context of the broader market, INNV competes directly with industry leaders such as SDGR and BBAI. With a market capitalization of $1.47B, it holds a significant position in the sector. When comparing efficiency, INNV's gross margin of 22.27% stands against SDGR's 55.07% and BBAI's 32.79%. Such benchmarking helps identify whether InnovAge Holding Corp is trading at a premium or discount relative to its financial performance.

The company has shown revenue growth, with Q3 FY2026 revenue at $251.9 million, a 15.5% increase year-over-year, but it also reported a net loss of $29.9 million, highlighting profitability challenges.